FIELD: medicine. SUBSTANCE: method involves administering inhalations with hypertonic sodium chloride solution. Concentration is increased in known step succession. The beginning concentration is 3% solution. The concentration is increased to 7% in the following days with 2-3% large increments. Higher concentration is set depending on clinical manifestations of side effects. EFFECT: reduced bronchial hyperreactivity; accelerated treatment course. 1 tbl
Authors
Dates
2000-10-20—Published
1999-08-23—Filed